Products for Research Use Only
RegisterLogin

Siplizumab

CAT: 0804-HY-P99904-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99904-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells[1].
CAS Number
288392-69-8
Product Name Alternative
MEDI-507
UNSPSC
12352203
Target
CD2
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/siplizumab.html
Purity
99.83
Solubility
10 mM in DMSO
Smiles
[Siplizumab]
Molecular Weight
(146.25 kDa)
References & Citations
[1]Binder C, et, al. Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro. Front Immunol. 2020 Nov 11;11:592553.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
abx831017-01Siplizumab
GTR18338146-01Siplizumab Antibody
047912CD2 (siplizumab) discontinued
MBS1563419-01Research Grade Siplizumab
KBI1633KRIBIOLISA™ Siplizumab ELISA
A2562-1mg*25Siplizumab (Anti-CD2)
MBS1586371-01Siplizumab ELISA Kit
E55B0296Siplizumab (Reference antibody)
592199Siplizumab (CD2, LFA-2)
F1358-50Anti-CD2 Antibody (Siplizumab)

Popular Products